The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials

Overview of attention for article published in The Journal of Headache and Pain, January 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 10,850 followers.

RT @EHF_Official: A meta-analysis of available studies assessing the efficacy and safety of the oral #GCRP receptor blocker #atogepant. The…

17 Feb 2022

Reply Repost Favourite

RT @EHF_Official: A meta-analysis of available studies assessing the efficacy and safety of the oral #GCRP receptor blocker #atogepant. The…

16 Feb 2022

Reply Repost Favourite

RT @EHF_Official: A meta-analysis of available studies assessing the efficacy and safety of the oral #GCRP receptor blocker #atogepant. The…

15 Feb 2022

Reply Repost Favourite

A meta-analysis of available studies assessing the efficacy and safety of the oral #GCRP receptor blocker #atogepant. The results are very positive and assuring, further studies are expected. Article in full: https://t.co/WH5EKvYSiv #migraine #headache #

15 Feb 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.